Research Service, VA Portland Health Care System, 3710 SW US Veterans Hospital Rd., Portland, OR, 97239, USA.
Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR, 97239, USA.
Psychopharmacology (Berl). 2019 Mar;236(3):939-952. doi: 10.1007/s00213-018-5059-5. Epub 2018 Nov 5.
New psychoactive substances (NPSs), including substituted cathinones and other stimulants, are synthesized, sold on the Internet, and ingested without knowledge of their pharmacological activity and/or toxicity. In vitro pharmacology plays a role in therapeutic drug development, drug-protein in silico interaction modeling, and drug scheduling.
The goal of this research was to determine mechanisms of action that may indicate NPS abuse liability.
Affinities to displace the radioligand [I]RTI-55 and potencies to inhibit [H]neurotransmitter uptake for 22 cathinones, 6 benzofurans and another stimulant were characterized using human embryonic kidney cells stably expressing recombinant human transporters for dopamine, norepinephrine, or serotonin (hDAT, hNET, or hSERT, respectively). Selected compounds were tested for potencies and efficacies at inducing [H]neurotransmitter release via the transporters. Computational modeling was conducted to explain plausible molecular interactions established by NPS and transporters.
Most α-pyrrolidinophenones had high hDAT potencies and selectivities in uptake assays, with hDAT/hSERT uptake selectivity ratios of 83-360. Other substituted cathinones varied in their potencies and selectivities, with N-ethyl-hexedrone and N-ethyl-pentylone having highest hDAT potencies and N-propyl-pentedrone having highest hDAT selectivity. 4-Cl-ethcathinone and 3,4-methylenedioxy-N-propylcathinone had higher hSERT selectivity. Benzofurans generally had low hDAT selectivity, especially 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine, with 25-fold higher hSERT potency. Consistent with this selectivity, the benzofurans were releasers at hSERT. Modeling indicated key amino acids in the transporters' binding pockets that influence drug affinities.
The α-pyrrolidinophenones, with high hDAT selectivity, have high abuse potential. Lower hDAT selectivity among benzofurans suggests similarity to methylenedioxymethamphetamine, entactogens with lower stimulant activity.
新精神活性物质(NPSs),包括取代的卡西酮和其他兴奋剂,在互联网上被合成、销售,并在不知道其药理活性和/或毒性的情况下被摄入。体外药理学在治疗药物开发、药物-蛋白质计算机模拟相互作用和药物分类中发挥作用。
本研究的目的是确定可能表明 NPS 滥用倾向的作用机制。
使用稳定表达重组人多巴胺、去甲肾上腺素或 5-羟色胺转运体的人胚肾细胞,测定 22 种卡西酮、6 种苯并呋喃和另一种兴奋剂对放射性配体 [I]RTI-55 的亲和力和抑制 [H]神经递质摄取的效力。选择的化合物在通过转运体诱导 [H]神经递质释放方面的效力和功效进行了测试。进行了计算建模,以解释 NPS 和转运体之间建立的合理分子相互作用。
大多数 α-吡咯烷苯乙酮在摄取测定中具有高 hDAT 效力和选择性,hDAT/hSERT 摄取选择性比为 83-360。其他取代的卡西酮在效力和选择性上有所不同,N-乙基-己酮和 N-乙基-戊基酮具有最高的 hDAT 效力,N-丙基-戊基酮具有最高的 hDAT 选择性。4-Cl-乙基卡西酮和 3,4-亚甲二氧基-N-丙基卡西酮具有更高的 hSERT 选择性。苯并呋喃一般对 hDAT 选择性低,特别是 1-(2,3-二氢苯并呋喃-5-基)-N-甲基丙-2-胺,对 hSERT 的效力高 25 倍。与这种选择性一致,苯并呋喃是 hSERT 的释放剂。建模表明转运体结合口袋中的关键氨基酸会影响药物亲和力。
具有高 hDAT 选择性的 α-吡咯烷苯乙酮具有很高的滥用潜力。苯并呋喃中较低的 hDAT 选择性表明与 3,4-亚甲二氧基甲基苯丙胺相似,后者具有较低的刺激活性。